KRAS status and efficacy of first-line treatment of patients with metastatic colorectal cancer (mCRC) with FOLFOX with or without cetuximab: The OPUS experience. - Bokemeyer,C.; Bondarenko,I.; Hartmann,J.T. (J Clin Oncol, 2008)